The US Food and Drug Administration issued a warning letter to Professional Compounding Centers of America (PCCA) for receiving and distributing adulterated and misbranded active pharmaceutical ingredients (APIs).

https://www.thepharmaletter.com/article/fda-warns-compounder-for-putting-consumers-at-risk-with-misbranded-drug-ingredients